HOW DO GLUCOCORTICOIDS, BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DISEASE ACTIVITY IMPACT THE RISK OF STAPHYLOCOCCUS AUREUS BACTEREMIA IN RHEUMATOID ARTHRITIS PATIENTS? A NATIONWIDE NESTED CASE CONTROL STUDY IN THE DANISH DANBIO COHORT

S. Dieperink, B. Glintborg, F. Mehnert, M. Norgaard,T. Benfield, C. Torp-Pedersen, L. B. Oestergaard,A. Petersen, M. L. Hetland

ANNALS OF THE RHEUMATIC DISEASES（2022）

引用 0|浏览1

暂无评分

关键词

rheumatoid arthritis patients,rheumatoid arthritis,disease-modifying activity,aureus bacteremia,anti-rheumatic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要